![Brian Blakey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brian Blakey
Corporate Officer/Principal en
STEALTH BIOTHERAPEUTICS CORP
.
Perfil
Brian D.
Blakey is currently the Chief Business Officer at Stealth BioTherapeutics Corp.
and Stealth BioTherapeutics, Inc. He previously worked as a Director at GSK Plc from 1998 to 2004, as Vice President-Marketing at AtheroGenics, Inc. from 2006 to 2010, and as Chief Operations & Strategy Officer at Ogilvy Commonhealth Market Access from 2010 to 2014.
He received a doctorate degree from the University of Florida in 1986.
Cargos activos de Brian Blakey
| Empresas | Cargo | Inicio |
|---|---|---|
| STEALTH BIOTHERAPEUTICS CORP | Corporate Officer/Principal | 01/02/2014 |
Stealth BioTherapeutics, Inc.
 Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat the mitochondrial dysfunctions and age-related diseases | Corporate Officer/Principal | 01/02/2014 |
Antiguos cargos conocidos de Brian Blakey.
| Empresas | Cargo | Fin |
|---|---|---|
Ogilvy Commonhealth Market Access
 Ogilvy Commonhealth Market Access Advertising/Marketing ServicesCommercial Services Provides medical marketing services | Director de Operaciones | 01/02/2014 |
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Corporate Officer/Principal | 01/05/2010 |
| GSK PLC | Director/Miembro de la Junta | 01/02/2004 |
Formación de Brian Blakey.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
81
Relaciones de 1er grado
6
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ogilvy Commonhealth Market Access
Ogilvy Commonhealth Market Access Advertising/Marketing ServicesCommercial Services Provides medical marketing services | Commercial Services |
Stealth BioTherapeutics Corp.
 Stealth BioTherapeutics Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops investigational drugs for the treatment of diseases involving mitochondrial dysfunction | Health Technology |
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat the mitochondrial dysfunctions and age-related diseases | Health Technology |
- Bolsa de valores
- Insiders
- Brian Blakey
